{"Abstract": [0], "Ovarian": [1], "cancer": [2, 11, 213], "is": [3, 25, 48, 163], "the": [4, 16, 23, 42, 72, 106, 133, 136, 217], "second": [5], "most": [6], "common": [7], "cause": [8], "of": [9, 31, 52, 74, 138, 176, 187, 219], "gynecologic": [10], "death": [12], "in": [13, 50, 77, 89, 105, 114, 120, 154, 211], "women": [14, 125], "around": [15], "world.": [17], "The": [18], "outcomes": [19], "are": [20, 143], "complicated,": [21], "because": [22], "disease": [24, 67], "often": [26], "diagnosed": [27], "late": [28], "and": [29, 37, 46, 53, 68, 83, 118, 148, 179, 201, 208, 214], "composed": [30], "several": [32], "subtypes": [33], "with": [34, 71, 126, 145], "distinct": [35], "biological": [36], "molecular": [38, 147], "properties": [39], "(even": [40], "within": [41], "same": [43], "histological": [44], "subtype),": [45], "there": [47], "inconsistency": [49], "availability": [51], "access": [54, 158], "to": [55, 64, 159], "treatment.": [56], "Upfront": [57], "treatment": [58, 137], "largely": [59], "relies": [60], "on": [61], "debulking": [62], "surgery": [63], "no": [65], "residual": [66], "platinum\u2010based": [69], "chemotherapy,": [70, 193], "addition": [73], "antiangiogenic": [75], "agents": [76], "patients": [78, 188], "who": [79, 189], "have": [80, 111], "suboptimally": [81], "debulked": [82], "stage": [84], "IV": [85], "disease.": [86], "Major": [87], "improvement": [88], "maintenance": [90], "therapy": [91], "has": [92], "been": [93, 112], "seen": [94], "by": [95], "incorporating": [96], "inhibitors": [97], "against": [98], "poly": [99], "(ADP\u2010ribose)": [100], "polymerase": [101], "(PARP)": [102], "molecules": [103], "involved": [104], "DNA": [107], "damage\u2010repair": [108], "process,": [109], "which": [110], "approved": [113], "a": [115, 121, 199], "recurrent": [116], "setting": [117, 123], "recently": [119], "first\u2010line": [122], "among": [124], "BRCA1": [127], "/": [128], "BRCA2": [129], "mutations.": [130], "In": [131, 165], "recognizing": [132], "challenges": [134], "facing": [135], "ovarian": [139, 212], "cancer,": [140], "current": [141], "investigations": [142], "enlaced": [144], "deep": [146], "cellular": [149], "profiling.": [150], "To": [151], "improve": [152], "survival": [153], "this": [155], "aggressive": [156], "disease,": [157], "appropriate": [160], "evidence\u2010based": [161], "care": [162], "requisite.": [164], "concert,": [166], "realizing": [167], "individualized": [168], "precision": [169], "medicine": [170], "will": [171, 184, 204], "require": [172], "prioritizing": [173], "clinical": [174, 207], "trials": [175], "innovative": [177], "treatments": [178], "refining": [180], "predictive": [181], "biomarkers": [182], "that": [183], "enable": [185], "selection": [186], "would": [190], "benefit": [191], "from": [192], "targeted": [194], "agents,": [195], "or": [196], "immunotherapy.": [197], "Together,": [198], "coordinated": [200], "structured": [202], "approach": [203], "accelerate": [205], "significant": [206], "academic": [209], "advancements": [210], "meaningfully": [215], "change": [216], "paradigm": [218], "care.": [220]}